...
首页> 外文期刊>Digestive surgery >Metzenbaum-Assisted Liver Resection: A Safe and Effective Liver Resection Technique
【24h】

Metzenbaum-Assisted Liver Resection: A Safe and Effective Liver Resection Technique

机译:Metzenbaum辅助肝切除术:一种安全有效的肝切除术

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: We hereby present and evaluate a technique for hepatic parenchymal transection based on the application of Metzenbaum scissors and clips during liver ischemia. Methods: Our technique was retrospectively evaluated in 32 noncirrhotic, noncholestatic patients with intrahepatic cholangiocarcinoma and 32 patients with hepatocellular carcinoma (23 of whom cirrhotic, 71.9%). Patient data were retrieved from our Hepatobiliary Surgery Database. Type and duration of vascular clamping, blood transfusion requirements, marginal status and immediate postoperative complications were analyzed. Results: Twenty-seven extended (>4 liver segments; 42.2%) and 37 nonextended (<= 4 liver segments; 57.8%) liver resections were analyzed. Warm liver ischemia duration was 14 (interquartile range: 11-17.8) min. Thirty-three patients (51.6%) were transfused with a median of 2 (1.5-3) units of packed red blood cells. Tumor-free margins were achieved in 90.6% of cases (n = 58). The overall morbidity rate was 18.8% with a 4.7% mortality rate. Our technique allowed for excellent identification and safe dissection and preservation, or ligation of major liver vessels. Conclusions: The proposed technique is simple, fast, safe and with low cost. It is associated with limited postoperative complications while from an oncologic standpoint it enables the surgeon to achieve a high percentage of tumor-free margins while protecting major vascular structures. (C) 2014 S. Karger AG, Basel
机译:目的:我们在此基础上,基于Metzenbaum剪刀和夹子在肝脏缺血期间的应用,提出并评估一种用于肝实质横切的技术。方法:对32例非肝硬化,非胆汁淤积性肝内胆管癌和32例肝细胞癌(其中23例肝硬化,占71.9%)进行回顾性评估。从我们的肝胆外科手术数据库中检索患者数据。分析了血管夹持的类型和持续时间,输血需求,边缘状态和术后即刻并发症。结果:分析了二十七例扩大的(> 4个肝段; 42.2%)和37例未扩大的(<= 4个肝段; 57.8%)肝切除。温暖的肝脏缺血持续时间为14分钟(四分位间距:11-17.8)分钟。向33例患者(51.6%)输注了2个(1.5-3)单位堆积红细胞。 90.6%的病例实现了无肿瘤切缘(n = 58)。总体发病率为18.8%,死亡率为4.7%。我们的技术可实现出色的识别,安全解剖和保存,或结扎主要肝血管。结论:所提出的技术简单,快速,安全,成本低。它与有限的术后并发症相关,而从肿瘤学的角度来看,它使外科医生能够在保护主要血管结构的同时实现高百分比的无肿瘤切缘。 (C)2014 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号